The Day Lion Was King


At 7 am on August 11, about 200 Lion Bioscience staffers, friends, and family, wearing plastic wristbands and corporate-blue baseball caps, piled into buses in the company’s parking lot in Heidelberg and set out on the Autobahn to Frankfurt.

It was IPO day and everybody was invited. Thure Etzold, inventor of Lion’s SRS product, jetted back from a vacation in Cuba for the event, as did seven UK staffers, and six from the US.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The New York Times and ProPublica look into the close relationship between a startup and Memorial Sloan Kettering Cancer Center.

Yahoo News reports millions of dollars are being transferred from NIH, CDC, and other programs to pay for the housing of detained undocumented immigrant children.

In Science this week: in vitro generation of human reproductive cells, and more.

Researchers gave a handful of octopuses MDMA to find that they too act more social on the drug, Gizmodo reports.